Overview

Study of SOM0226 in Familial Amyloid Polyneuropathy

Status:
Completed
Trial end date:
2015-11-01
Target enrollment:
Participant gender:
Summary
Clinical proof of concept study to evaluate SOM0226 efficacy in TTR Amyloidosis.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
SOM Biotech SL
Collaborator:
Hospital Vall d'Hebron
Treatments:
Tolcapone